Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours
(Q40592751)
scientific article published on May 1, 2003
scientific article published on May 1, 2003
Language:
other details
description | scientific article published on May 1, 2003 |
External Links
(P356) |
10.1016/S0959-8049(03)00057-1
|
(P698) |
12706360
|